文献速递帕金森病与运动障碍

EIF2AK2错义变异与早发性全身性肌张力障碍相关

EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia.
PubMed 文献 · Ann Neurol · 2020-12-15

该研究通过全基因组连锁分析、外显子与Sanger测序、临床神经学检查、脑MRI及患者皮肤成纤维细胞蛋白表达研究,旨在确定早发性全身性肌张力障碍的单基因病因。结果在台湾一家族5例早发性孤立性全身性肌张力障碍患者中鉴定出EIF2AK2基因杂合变异c.388G>A p.Gly130Arg共分离,并在191例不明原因肌张力障碍患者中检出相同变异2例、不同杂合变异c.413G>C p.Gly138Ala 1例及纯合变异c.95A>C p.Asn32Thr 1例;这些变异均位于功能域且不见于gnomAD,患者成纤维细胞显示PKR介导的eIF2α磷酸化增强。

要点

  • EIF2AK2错义变异可致早发性全身性肌张力障碍,呈显性、隐性或新发遗传。
  • 患者成纤维细胞显示PKR介导的eIF2α磷酸化增强,提示细胞应激反应通路异常。
  • 部分患者可伴智力障碍和痉挛等额外神经表现。

核心结论

  • EIF2AK2变异与早发性全身性肌张力障碍相关,可显性、隐性遗传或新发出现。
  • 研究为eIF2α通路功能障碍在肌张力障碍发病中的关键作用提供直接证据。

研究设计与样本

  • 采用全基因组连锁分析、外显子与Sanger测序、临床神经学检查、脑MRI及患者皮肤成纤维细胞蛋白表达研究。
  • 在台湾一家族5例早发性孤立性全身性肌张力障碍患者中鉴定共分离变异,并在191例不明原因肌张力障碍患者中测序EIF2AK2。

主要发现

  • 台湾家族5例患者携带EIF2AK2杂合变异c.388G>A p.Gly130Arg并与早发性孤立性全身性肌张力障碍共分离。
  • 191例不明原因肌张力障碍中检出2例无关高加索患者携带相同杂合变异c.388G>A p.Gly130Arg(其中1例为新发)。
  • 另检出1例携带不同杂合变异c.413G>C p.Gly138Ala,1例近亲婚配患者携带纯合变异c.95A>C p.Asn32Thr。
  • 3个错义变异均不见于gnomAD,且位于编码蛋白的功能域。
  • 3例患者存在智力障碍和痉挛等额外神经表现。

关键数值与推荐

  • EIF2AK2错义变异c.388G>A p.Gly130Arg、c.413G>C p.Gly138Ala和c.95A>C p.Asn32Thr均不见于gnomAD。
  • 这些变异位于EIF2AK2编码蛋白的功能域。
  • 患者成纤维细胞中PKR介导的eIF2α磷酸化增强。

临床怎么用

  • 对早发性全身性肌张力障碍患者可考虑EIF2AK2基因检测。
  • 发现EIF2AK2错义变异时需评估遗传模式(显性、隐性或新发)并关注智力障碍和痉挛等伴随表现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study was undertaken to identify a monogenic cause of early onset, generalized dystonia. METHODS: Methods consisted of genome-wide linkage analysis, exome and Sanger sequencing, clinical neurological examination, brain magnetic resonance imaging, and protein expression studies in skin fibroblasts from patients. RESULTS: We identified a heterozygous variant, c.388G>A, p.Gly130Arg, in the eukaryotic translation initiation factor 2 alpha kinase 2 (EIF2AK2) gene, segregating with early onset isolated generalized dystonia in 5 patients of a Taiwanese family. EIF2AK2 sequencing in 191 unrelated patients with unexplained dystonia yielded 2 unrelated Caucasian patients with an identical heterozygous c.388G>A, p.Gly130Arg variant, occurring de novo in one case, another patient carrying a different heterozygous variant, c.413G>C, p.Gly138Ala, and one last patient, born from consanguineous parents, carrying a third, homozygous variant c.95A>C, p.Asn32Thr. These 3 missense variants are absent from gnomAD, and are located in functional domains of the encoded protein. In 3 patients, additional neurological manifestations were present, including intellectual disability and spasticity. EIF2AK2 encodes a kinase (protein kinase R [PKR]) that phosphorylates eukaryotic translation initiation factor 2 alpha (eIF2α), which orchestrates the cellular stress response. Our expression studies showed abnormally enhanced activation of the cellular stress response, monitored by PKR-mediated phosphorylation of eIF2α, in fibroblasts from patients with EIF2AK2 variants. Intriguingly, PKR can also be regulated by PRKRA (protein interferon-inducible double-stranded RNA-dependent protein kinase activator A), the product of another gene causing monogenic dystonia. INTERPRETATION: We identified EIF2AK2 variants implicated in early onset generalized dystonia, which can be dominantly or recessively inherited, or occur de novo. Our findings provide direct evidence for a key role of a dysfunctional eIF2α pathway in the pathogenesis of dystonia. ANN NEUROL 2021;89:485-497.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Kuipers DJS, Mandemakers W, Lu CS, et al. EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia. Ann Neurol. 2020. PMID: 33236446. doi:10.1002/ana.25973

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。